30It follows that Article 14(7) of Directive 2008/48 merely confers on Member States the option of laying down provisions establishing a period of time during which the performance of the contract may not begin, outside the framework of the regime established by that directive (see, by analogy, judgments of 20 November 2014, Novo Nordisk Pharma, C‑310/13, EU:C:2014:2385, paragraphs 25 and 29, and of 19 November 2019, TSN and AKT, C‑609/17 and C‑610/17, EU:C:2019:981, paragraph 49).
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.